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Résumé 
Les protéases spécifiques à l'ubiquitine (<< ubiquitin-specific proteases » ou USPs) 
représentent un sous-ensemble important d'enzymes de dé-ubiquitination humaines 
(DUBs) qui catalysent la libération d'ubiquitine des protéines ubiquitinées. 
L'annotation fonctionnelle de ces enzymes est limitée aux méthodes de comparaison 
par séquences par l'absence de données structurelles. Ainsi, la fonction des régions 
longues en amont et en aval du domaine catalytique ainsi que de celles encastrées à 
l'intérieur demeure inconnue. Dans l'article High Incidence of Ubiquitin-like 
Domains in Human Ubiquitin-Specific Proteases ci-présenté, nous démontrons la 
présence de nouvelles régions structurées et fonctionnelles chez les USPs humaines. 
Afin d'élargir notre compréhension sur la fonction de ces enzymes, nous avons 
appliqué la méthode de prédiction de repliement par consensus aux régions non-
annotées des USPs. Notre prédiction à haute fiabilité suggère que le domaine 
apparenté à l'ubiquitine (<< ubiquitin-like» ou UBL) constitue le domaine le plus 
fréquent dans la famille des USPs humaines. La présence des UBLs en copies 
multiples ainsi qu'insérés au sein du domaine catalytique de certaines USPs 
démontrent d'un haut degré de complexité structurale. Ces données complémentent 
nos connaissances actuelles sur l'organisation structurelle et fonctionnelle de 
l'ensemble des DUBs. Nos résultats suggèrent que la présence des UBLs est 
quasiment aussi fréquente que le domaine catalytique. Nous proposons diverses 
fonctions possibles pour des nouveaux domaines UBLs découverts chez les USPs 
humaines, telles que l'association avec le protéasome, le recrutement spécifique de 
substrats, ainsi que la distribution intracellulaire. 
Mots clés: dé-ubiquitination, prédiction de repliement, protéasome, ubiquitine, UBL, 
USP. 
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Abstract 
The family of ubiquitin-specific proteases (USPs) is the major member of the 
human deubiquitinating enzymes (DUBs) superfamily that specifically cleaves 
ubiquitin from ubiquitin-conjugated substrates. CUITent functional annotations of 
USPs is limited to sequence comparison methods and to the minimal availability of 
crystallographic data. Large regions both within and flanking the catalytic core which 
may explain substrate specificity and subcellular localization remain poorly defined. 
In the article presente d, High Incidence of Ubiquitin-like Domains in Human 
Ubiquitin-Specific Proteases, we provide evidence of the presence of novel structural 
features and domains within the human USPs. Our methods utilize consensus prote in 
fold recognition techniques on stretches of un-annotated regions in the USPs in order 
to expand our CUITent understanding of the functional role of these enzymes. Among 
other interesting findings, we have discovered a high occurrence of reliably predicted 
ubiquitin-like (UBL) folds situated at both N- and C-terminal regions as weIl as 
embedded within the catalytic core of human USPs. The marked presence of multiple 
UBL domains as well as those integrated within the catalytic core present a new 
dimension in the structural complexity of these enzymes. Our results also suggest that 
the occurrence of UBL do mains in human USPs is a close second to the characteristic 
catalytic core. Several propositions for the functional implications including 
proteasome binding and substrate recognition of these UBLs are discussed. 
Keywords: deubiquitination, consensus fold recognition, proteasome, ubiquitin, UBL, 
USP 
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Chapter 1 Introduction 
Post-translational modifications modulate enzyme activity and generate new 
dimensions to complex biological processes. In eukaryotes, the fate of a protein is 
often determined by attachment of ubiquitin moieties through covalent yet 
hydrolyzable enzyme mediated linkages. Polyubiquitination, the attachment of a 
polymerie ubiquitin chain, is classically known for its direct involvement in 
modulation of ubiquitin-mediated proteasomal degradation and, like the attachment of 
a single ubiquitin molecule, is involved in a multitude of biological functions from 
endocytosis to cell proliferation. 
Ubiquitin is a small 76-residue prote in involved in post-translational 
modifications that help to modulate diverse biological pathways. The ubiquitin 
pathway includes two biochemical phenomena: ubiquitination and deubiquitination. 
Ubiquitination is a reversible post-translational modification that involves the 
covalent linkage of ubiquitin molecules to a target protein. Deubiquitination, 
performed by deubiquitinating enzymes (DUBs), can cleave the isopeptide bond 
between ubiquitin and the site of attachment. In addition to reversing ubiquitination, 
DUBs are also involved in the activation of ubiquitin and ubiquitin-like modifiers 
through C-terminal processing of their precursors. The ubiquitin pathway is involved 
in a wide array of biological functions including DNA repair, signal transduction, 
membrane protein trafficking, endocytosis, transcription, nuclear transport, and 
proteolysis. The family of human enzymes ubiquitin-specific proteases (USPs) 
constitutes the majority of DUBs. Although biological studies over the past decade 
have significantly contributed to the current structural and functional inventory of 
DUBs, we still know little about the physiological roles and mechanisms of 
intermolecular interactions of most USPs. 
In human, there are currently 54 USPs known with high variance in length and 
domain architecture. Our current understanding of the structure and function ofUSPs 
is the result of a combination of bioinformatics predictions and experimental efforts. 
In addition to the evident presence of a catalytic core homologous to ubiquitin C-
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terminal hydrolases (UCH), many USPs are found, mostly by sequence-based 
comparison techniques and probabilistic models such as BLAST, SMART, Pfam, and 
PROSITE, to harbor rather unrelated domain architectures outside the UCH domain 
(Nijman et al. 2005). For example, zinc-fingers are observed at the N-terminal region 
of sorne USPs (USP3, 5, 13, 16, 20, 22,33,44, and 49) while others have ubiquitin-
associated do mains (UBA) placed in tandem at the heart of the catalytic core. Despite 
current efforts in the annotation and characterization of these enzymes, large portions 
of the N- and C-terminal extensions of human USPs remain structurally and 
functionally un-annotated. In addition, the length of their catalytic core domains 
varies from approximately 300 to 800 residues due to large uncharacterized insertions 
which may play important physiological roles. This lacuna in functional assignment is 
a direct indication that ev en the most sensitive evolution-based sequence comparisons 
may not be sufficient to infer functional homologies. 
The objective of this study is to develop and apply a methodology to structurally 
annotate previously un-annotated regions of the 54 putative human USPs. Possible 
functions of the resulting predictions will be inferred and discussed from predicted 
folds. Given the currently known and anticipated biological roles for USPs, our 
comprehensive structural annotation of these members of the DUB family provides 
important stepping stones towards elucidating their precise involvements in many 
hum an diseases. 
In order to better understand the objectives and results, biological and 
computational background related to the subject will be presented over the next two 
chapters. First, the fundamentals of the prominent ubiquitin pathway will be 
discussed in Chapter 2. The next section, Chapter 3, confers the fundamentals of the 
bioinformatics aspect of our study to the reader. From sequence alignment to 
structure prediction, key information conceming classical and structural-
bioinformatics give the reader the fundamentals necessary to comprehend our choice 
of method and the power of our predictions. In addition, the fundamentals of the key 
tool employed in our study will be presented. The pub li shed article will then be 
presented in Chapter 4. 
Chapter 2 Biological Background 
In this chapter, an overview of structural and functional properties of type 1 and 
type 2 ubiquitin-like (UBL) modifiers will first be presented. Next, the two 
fundamental processes that constitute the ubiquitin modification of proteins will be 
explored: ubiquitination, the attachment of ubiquitin molecules cnte a protein target, 
and deubiquitination, their removal. Structural and functional aspects of 
deubiquitinating enzymes (DUBs), the focus of present study, will be presented in 
greater detail. 
2.1 Ubiquiton: the ubiquitin superfold 
Ubiquitin and UBL structures belong to the ~-grasp c1ass of structural folds. It boasts 
a beta-sheet wrapped around a central a-helix mu ch like the grasp of a hand (Figure 
1). The central helix flanked by two upstream and three downstream consecutive 
beta-sheets is characteristic to secondary structure arrangements of ubiquitin and 
consensus of its umbrella family: ubiquitons. A three-residue 3 w-helical turn often 
follows immediately after the central a-helix in many UBLs. 
Figure 1: Cartoon representation ofubiquitin (PDB: lAAR). AlI 7 lysine residues are 
shown (red). 
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ln biological systems, the functional role of a prote in is not only controlled by its 
level of expression but also by post-translational processes during which chemical 
modifications of the polypeptide modulate its activity, sub-cellular localization, and 
elimination. In eukaryotes, there exists a post-translational process widely known as 
ubiquitination, which is analogous to, but biologically distinct from, phosphorylation, 
and which consists in the addition of ubiquitin moieties to protein targets. Molecules 
that have a covalent mode-of-action resembling the C-terminal attachment of 
ubiquitin are commonly termed UBL molecules or type 1 ubiquitons. In contrast, 
there also exist UBL structures that are embedded within a larger protein, which 
constitute the type II class of uhiquitons. 
2.1.1 Type 1: ubiquitin and ubiquitin-like modifiers 
Ubiquitin (Ub) is a small and highly conserved molecule abundant in 
eukaryotes. Its 3D structure is representative of the UBL fold, which is shared by a 
large number of protein sequences showing remarkable structural similarities while 
displaying divergent sequence homology (Kiel, Serrano 2006). This 76-residue 
polypeptide acts as a signaling marker that effectively guides the target protein 
through various biological pathways. The Ub-Iabeling of a target prote in is usually a 
result of the formation of a covalent linkage between the C-terminus of Ub and the E-
amino group of a substrate lysine residue (Figure 2A). This reversible process is 
commonly known as ubiquitination and is govemed by the sequential action of three 
enzymes: El, E2 and E3, as will be described in the following section. There also 
exist several small proteins of close structural resemblance to ubiquitin, which have 
rather divergent sequence similarities and functions, but share with Ub the same 3D-
structural. fold and the covalent mode-of-action via a reactive C-terminus glycine 
(Welchman et al. 2005). The most studied type 1 UBL molecules are SUMO isoforms, 
NEDD8, ISG15 and FATIO with functional roles ranging from transcriptional 
regulation (SUMO) to E3 regulation (NEDD8) to immune response (lSG 15) to 
apoptosis (Welchman et al. 2005). 
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Figure 2: Target labeling by ubiquitin(s). (A) The pro cess of ubiquitination is guided 
by the sequential actions of E 1, E2, and E3 enzymes. (B) There exist three modes of 
Ub attaclunent: mono-, multi-, and polyubiquitination. 
2.1.2 Type II: integral ubiquitin motifs 
Ubiquitin-like structures also exist as integral elements of larger proteins. These 
genetically built-in UBL domains can be located anywhere in the sequence, although 
N-terminal UBL structures are prevalent in CUITent knowledge bases. Type II UBL 
structures generally play integral roles in protein-protein interaction, subcellular 
localization, as weIl as intrinsic modulation of enzyme activity. Integral UBLs have 
also been shown to associate with the 19S subunit of the 26S proteasome primarily by 
interacting directly with ubiquitin-interacting motifs (UlM) of the proteasome. For 
example, UBL domain-containing protein Rad23 , which also contains a regulatory 
ubiquitin-associated domain (UBA), was shown to deliver polyubiquitinated 
substrates to the proteasome for degradation. (Walters et al. 2004) 
2.2 Ubiquitin modification pathways 
The previous section described the two types of ubiquitons. We will now 
introduce the biochemical mechanism which underlies different mode of attaclunent 
ofubiquitin and ubiquitin-like molecules. 
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2.2.1 Ubiquitination 
Ubiquitination is defined by the covalent linkage of Ub onto a target prote in via 
formation of a bond typically between the C terminus (Gly76) of Ub and the E-amino 
group of a substrate lysine residue. It is a three-part process mediated by sequential 
action of El activating, E2 conjugating, and E3 ubiquitin-protein ligating enzymes 
and initiates all known types of ubiquitination . The carboxyl group of Gly76 forms a 
thiol ester with El, activating the C terminus of Ub for a nucleophilic attack. This 
activated Ub is transiently carried by an E2 to an E3, which in turn specifically 
recognizes and facilitates transfer of the Ub to a substrate (Pickart, Eddins 2004). 
In eukaryotes, there exist three modes for ubiquitin modification, each 
distinguished by its characteristic pattern of attachment which triggers distinct 
biological pathways. First, monoublquitination is defined by the linkage of a single 
Ub molecule to a single site on a target protein. Second, multi-monoubiquitination 
involves monoubiquitination at multiple sites. Last, polyubiquitination consists of the 
addition of a polyubiquitin chain constituting two or more covalently linked Ub 
molecules (Figure 2B). 
AlI 7 lysine residues of the 76 amino-acid Ub offer potential linkage sites for 
chain extension (Figure 1). In nature, however, Lys48 and Lys63 linkages are more 
commonly observed. Formation of Lys48-linked polyubiquitin chains is precursor to 
signaling a target prote in for proteasomal degradation and plays important roles in 
DNA repair and signal transduction. While Lys48-linked polyubiquitin chains can 
effectively target a protein to the proteasome for degradation, Lys63-linkage topology 
typically does not. The latter configuration is structurally different in comparison with 
Lys48-linkage and is generally recognized in DNA repair, signal transduction, and 
non-Iysosomal degradation. (Kerscher et al. 2006) In addition, Lys63-linked chains 
activates NF-lcB signaling pathway involved in inflammation, apoptosis, and 
tumorigenesis (Nijman et al. 2005). 
The general response of a cell following exposure to chemical and mechanical 
stress is an increase in intrinsic proteolysis. Stimulation of ubiquitin-dependant 
proteolytic system is one of the important elements in the proteolytic cascade and is 
shown to respond to a host of cellular stresses caused by viral infection, heat shock, 
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and protein damage (Wilkinson 1995). This destructive pathway is govemed by 
proteasomal degradation of polyubiquitinated target proteins. Once covalently tagged 
with a Lys48-linked polyubiquitin chain, the marked proteinis able to localize to the 
ubiquitin-interacting motif (UIM)-containing 198 subunit of the 268 proteasome and 
undergo proteolytic disassembly. The UlM is a short segment of about 20 residues 
that recognizes and binds to Ub and is often present in three consecutive copies 
within proteins, especially those involved in ubiquitin pathways. 
Monoubiquitination and multi-monoubiquitination are commonly associated with 
non-degrading processes such as endocytosis, regulation of transcription, and sorting 
of target proteins to the vacuole (Loayza, Michaelis 1998;80etens et aL 2001). 
Monoubiquitination was previously demonstrated in yeast and vertebrate cells to be 
sufficient to induce endocytosis of membrane-bound proteins and receptors. (Hicke, 
Dunn 2003;Peschard, Park 2003;Holler, Dikic 2004). Monoubiquitination is aiso 
involved in subcellular localization and in recruiting Ub binding proteins to specifie 
interacting partners (Nijman et al. 2005). 
2.2.2 Deubiquitination 
The reversaI of ubiquitination during which Ub moieties are excised is termed 
deubiquitination, a process mediated by members of the deubiquitinating enzyme 
(DUB) superfamily. Ubiquitin-specific proteases (U8P) are cysteine proteases and 
form a family of ubiquitin-processing enzymes that belong to the DUB superfamiIy. 
To date, more than 54 human U8Ps have been reported and summarized in recent 
research publications and reviews (Nijman et aL 2005;Quesada et aL 2004). These 
enzymes possess a catalytic core homologous to that of the papain superfamily of 
cysteine proteases. In human, the USP catalytic core domain varies from 300 to 850 
residues flanked by highly variable N- and C-terminal domain structures. Within the 
human USP family, homology exists primarily in the Cys-box and His-box regions 
harboring the catalytic residues. The highly divergent N- and C-terminal regions 
containing a variety of structural domains and functional motifs (e.g., zinc finger 
domains, EF-hand domains, UIMs) indicate an elevated structural and functional 
complexity within the USP family of DUBs. The large number of both validated and 
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predicted USPs suggests that these enzymes may exhibit selectivity for specific target 
proteins as weIl as the type of Ub conjugation. The current functional understanding 
ofUSPs relies largely on sequence-based comparisons. 
Despite the importance ofUSPs, which play key regulatory roles in a multitude of 
processes, our knowledge of their substrate specificity and precise mode of regulation 
is surprisingly scant compared to the sequence and structural landscape of this class 
of enzymes (Nijman et al. 2005). Human USPs harbor divergent domain structures in 
regions extending the catalytic core. Such diversity allows for narrow specificities for 
the target protein and substrate ubiquitin or ubiquitin chains as weIl as for modulation 
of activity of the se enzymes (Nijman et al. 2005). The dual property of target and 
substrate recognition of a particular prote in and ubiquitin branching, respectively, 
may further increase the degree of specificity of USPs. The ubiquitin pathway is weIl 
known for its key role in Ub-directed proteolysis of target proteins. Crystallographic 
studies have confirmed that USP14, which resides in and is regulated by the 26S 
proteasome, contains a previously identified N-terminus UBL domain that 
specifically associates with the 19S regulatory particle (Borodovsky et al. 2001 ;Hu et 
al. 2005;Nijman et al. 2005). Because oftheir structural dissimilarities, recognition of 
Lys48 and Lys63 linked poly-Ub chains often do not overlap. Amongst other 
branching-specific USPs, USP8 and USP14 exclusively cleave Lys48 but not Lys63 
linked poly-Ub chains. Such specificity may be acquired from regions flanking the 
catalytic core of USPs. In fact, the ubiquitin-interacting zinc finger (Znf-UBP) is one 
of the factors in USP 15 essential for disassembly of Ub polymers (Hetfeld et al. 
2005). Interestingly, USPs are also engaged in systems that involve modifications via 
UBL moieties. USP21 is an example of dual recognition of both Ub and NEDD8 
while USP 18 is shown to cleave and maintain cellular levels of ISG 15 (Gong et al. 
2000;Malakhov et al. 2002). 
In addition to Ub substrate specificity, regions outside the conserved catalytic 
core ofUSPs may play roles in target recognition as weiL In fact, many E3 ligases are 
targets for USPs. NRDP1, which ubiquitinates and promotes degradation of ErbB3, 
an epithelial growth factor receptor (EGFR), is deubiquitinated and stabilized by 
USP8 (Qiu et al. 2004;Wu et aL 2004). USP8 contains a rhodanese-like domain 
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which, in conjunction to its catalytic core, contributes to the recognition of 
polyubiquitinated NRDPl (Avvakumov et al. 2006). USP7, also known as HAUSP, 
can stabilize the E3 Mdm2, a p53 suppressor and lead to attenuation of p53 activity 
(Li et al. 2004). Disruption ofUSP7 activity was shown to effectively suppress tumor 
growth (Cummins et al. 2004). Moreover, USP7 can also deubiquitinate and stabilize 
p53, thereby possessing dual roles in p53 regulation (Li et al. 2004). Interestingly, 
USP7 harbors a TRAF-like MATH domain in the N-terminal region preceding the 
catalytic core that recognizes and binds to both p53 and Mdm2 (Hu et al. 2006). The 
primary objectives of the present study are to explore the sequence-to-structure-to-
function paradigm by applying structural bioinformatics tools on un-annotated 
regions of the 54 known human USP sequences to uncover novel information elusive 
to simple sequence comparison methods. 
2.2.3 Deubiquitination and diseases 
The implication of DUBs in human diseases has drawn significant attention and 
research interest to this class of enzymes in recent years. To demonstrate the extent of 
implications of USPs and other DUBs in human diseases, sorne examples are 
presented. 
The first direct evidence of the role of ubiquitination in tumor suppressor p53 
downregulation originated from human papillomavirus (HPV) studies. It was shown 
that degradation of turnor suppressor p53 was induced by an ubiquitin ligase complex 
in HPV. In fact, p53 is polyubiquitinated in cells infected by HPV leading to its 
proteasomal degradation (Scheffner et al. 1990;Scheffner et al. 1992). As previously 
noted, regulation of p53 is also modulated by Mdm2, a RING finger E3 that inhibits 
p53 activation function and downregulates its expression via polyubiquitination. 
Conversely, Mdm2 is itself regulated by p53 and these enzymes together form an 
auto-regulatory negative feedback loop in cell proliferation (Pickart, Eddins 2004). 
The USP7 enzyme, also known as herpesvirus-associated USP, or HAUSP, was 
originally observed to associate with herpes simplex virus-type 1 immediate-early 
Vmwll0, a RING finger protein required for efficient initiation of viral lytic cycle 
(Everett et al. 1997;Sacks, Schaffer 1987). Interestingly, USP7 specifically stabilizes 
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p53 via deubiquitination therefore inducing p53-mediated cell growth arrest and 
apoptosis (Cummins et al. 2004;Kim et al. 2003). In recent studies, the full length 
isoform of USP2 (USP2a) has been identified as an oncogenic enzyme that stabilizes 
fatty acid synthase (FAS) and Mdm2 via deubiquitination (Graner et aL 2004;Priolo 
et aL 2006;Stevenson et aL 2007). USP2a overexpression induces tumorigenesis via a 
mechanism opposing that ofUSP7. In contrast, the truncated form ofUSP2 promotes 
apoptosis when overexpressed in several cancer cell Hnes (Gewies, Grimm 2003). 
USP2 isoforms share a common catalytic core and differ only in the length of the N-
terminal regions. 
A significant increase in USP4 mRNA levelhas been reported in small cell 
tumors and in adenocarcinomas of the lung. USP4 has been shown to direcdy 
associate with retinoblastoma protein (PRb), a tumor suppressor protein known to be 
dysfunctional in a number of types of cancer, but does not exhibit deubiquitination 
activity (Blanchette et al. 2001). Nevertheless, A2Areceptor, involved in endoplasmic 
reticulum (ER) quality control, is a deubiquitination substrate for USP4 (Milojevic et 
aL 2006). In addition, reciprocity in activity between USP4 and its E3 ligase R052 
was also identified (Wada, Kamitani 2006). Further investigation is required to 
understand the precise implications of USP4 in oncogenesis. USP 15 also possesses a 
pRb-interacting motif and may be involved, in cell growth regulation via 
deubiquitination and thus stabilization of pRb. (Kim et aL 2003) 
Emerging evidence suggests that USP8 is involved in cellproliferation by 
inducing degradation of EGFR and growth factor receptor tyrosine kinases (RTK) 
(Daviet, Colland 2007). Initially identified as a cell growth regulator that modulates 
the ubiquitination state of several key proteins in proliferation, USP8 is able to cleave 
both linear and isopeptide-linked ubiquitin chains (Naviglio et aL 1998) to rescue and 
recycle Ub at late endosome. Several interaction partners and substrates were 
identified. In mouse, Ras-guanine nucleotide exchange factor CDC25 is 
deubiquitinated and stabilized by USP8. An Hrs-binding protein, Hbp, which is 
involved in receptor endo- and exocytocis binds to USP8 via a Src homology domain 
3 (SH3). USP8 was also shown to mediate T -cell anergy by preventing self-
ubiquitination and degradation of the transmembrane RING finger E3 ligase GRAIL, 
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which is cIosely linked to endocytic pathways. In a similar fashion, the catalytic core 
and rhodanese domains ofUSP8 were shown to bind to and stabilize NRDPl, an E3 
. ligase that mediates EGFR stabilization. (reviewed in Daviet, Colland 2007) 
The first study demonstrating the relationship between . DUBs and 
neurodegenerative diseases was the identification of the association of autosomal 
dominant point mutation in UCH-Ll with Parkinson's disease. Another ex ample of 
implications of DUBs in neurological dysfunction is that in mice, a single 
homozygous mutation in the· ataxia gene encoding USP 14 leads to severe tremors 
followed by hind limb paralysis and death (D'Amato, Hicks 1965). In fact, 
reinstatement of USPI4, for which abolishment of activity resulted in 35% decrease 
in Ub mono mers in most of the tissue, restored Ub levels and reinstated motor 
functions (Anderson et al. 2005;Crimmins et al. 2006). In addition, mouse homolog 
of USP25 shows connection with the expression of proliferative neuroepithelial cells 
and post-mitotic neurons. In brain cells of Down syndrome patients, the expression of 
USP25 was decreased 2-fold therefore providing cIues that USP25 may be involved 
in Down syndrome pathogenesis. (Cummins et al. 2004;Kim et al. 2003) 
USPs are also involved in spermatogenesis. Genetic screening of 576 infertile and 
96 fertile men revealed the link between USP9 and male infertility. A 4-bp deletion in 
the y chromosome-linked USP9 (USP9Y) was determined to be responsible for the 
absence of sperm in the semen of azoospermie men (Sun et al. 1999). 
These deubiquitination-related diseases further emphasize the CUITent need. for 
functional and structural annotations of USPs. The present study provides a first 
comprehensive examination of human USPs by looking at information beyond what 
the sequences alone can provide. Our computational approaches and methodology are 
further described in Chapter 3 and in the published paper. 
Chapter 3 Structural Bioinformatics 
This section will provide fundamental understanding of current tools in domain 
annotations and functional predictions. Sequence-based comparison methods will be 
briefly described. Fold recognition by threading methods will also be presented. 
Functional inference from a sequence-based and fold recognition methods will be 
discussed. The primary tool structure prediction methods used in this study, 3D-Jury, 
will be introduced in more detail. 
3.1 Current structural and functional repositories 
There exist several databases for the functions and structures of gene products. 
The NCBI (at the National Center for Biotechnology Information) is without question 
the pinnacle of all databases. Amongst other features, the GenBank database homed 
at NCBI contains sequence information, functional annotations, and have many useful 
cross-references. Sequence query in these databases is generally the first approach to 
annotating a new gene product with unknown functions. (Jenuth 2000) The Swiss-
Prot prote in knowledgebase is another weIl known database dedicated to proteins and 
contains cross-reference to a wide array of functional and structural databases 
including NCBI and RCSB's Protein Data Bank (PDB) (Bairoch et al. 2004). The 
latter database is the primary repository for atomic-resolution experimental structures 
of proteins and protein complexes. InterPro is the main portal to structural-functional 
repositories, including Pfam, SMART, ProDom, PRINTS, UniProt and ProSite. It 
also contains references to structural classification databases SCOP and CATH. 
3.2 Structural classifications 
The RCSB Protein Data Bank (PDB) is a weIl maintained and up-to-date 
collection of published structures of biomolecules determined either by NMR or X-
ray crystallography. There has been an exponential growth in the number of protein 
structures in the PDB over the past decade. Each protein structure is classified into 
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superfamilies of characteristic protein folds and further sorted into unique classes of 
closely related folds by two major classification methods: SCOP and CA TH. 
Structural Classification of Proteins (SCOP) distributes protein domains from 
structural classes down to folds regardless of sequence homology (Murzin et al. 1995). 
SCOP is considered as a standard in classification of prote in folds and relies largely 
on expert Interpretations of prote in structures. CATH is an acronym for the four main 
levels of hierarchical organization of structural folds: Class Architecture Topology 
Homology. Structural classification by CATH is a semi-automated consensus driven 
process guided by both sequence and structural homology information. Expert 
Interpretations occur at the final A-stage classification via visual inspections and 
cross-references (Orengo et al. 1997). However, as noted in the Introduction section, 
the growth in the number of new folds defined by these structure classifiers has 
reached a staIl. Therefore, it is believed that the structural classes at the present time 
form the basis of a great majority ofprotein structures in the PDB. 
Ubiquitin and UBL structures belong to the ~-grasp class of structural folds 
(SCOP entry d.15), which consists of a beta-sheet wrapped around a central a-helix 
much like the grasp of a hand (Figure 1). A central alpha-he li x tlanked by two 
upstream and three downstream consecutive beta-strands is characteristic to the 
secondary structure arrangement of ubiquitin and ubiquitons. A three-residue 310-
helical turn often follows immediately after the central a-helix in many UBLs. 
3.3 Prediction of function 
One of the main purposes of bioinformatics is to develop and implement 
computational methods to annotate the function of a given, typically newly 
discovered, gene product. Depending on the sequence identitylhomology to existing 
functionally annotated prote in sequences, functional Inference can be attempted by 
classical sequence-based approaches or/and via a structural bioinformatics route 
centered on fold detection methods. 
3.3.1 From sequence to function 
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The classical approach to functional inference essentially relies on the pairwise 
alignment of the new (query) sequence with those in functionally annotated prote in 
sequence databases (described in Section 3.l), aiming to identify hits with global or 
even local similarities that can provide hints about its functions. Another type of 
sequence-based comparison utilizes probabilistic models such as the hidden Markov 
chain (HMM) to compare a query sequence with a signature of probabilities for a 
particular sequence to occur rather than pairwise comparison of two sequences. 
Profile comparison is another widely used statistical approach that aligns a query 
sequence with a pre-determined sequence pattern characteristic to a group of 
sequences notably from the same family (Krogh et al. 1994). Profile building and 
comparison methods are more sensitive than direct pairwise alignment in detecting 
homology. These traditional evolutionary-based approaches to predict the function of 
a prote in generally yield reliable results when statistically significant homology exists 
between the query and one or more database sequences. 
The downfall of sequence-based functional assignment is that the relationship 
between sequence and function is neither unique nor straightforward. It is widely 
known that proteins exercising similar functions may exhibit divergent sequences, 
and vice versa. This can be explained through observations of structural similarities 
between two proteins even in the absence of sequence similarities, which brings about 
another phenomenon that similar structures may display similar functions. Therefore, 
structural homologies that are undetectable with sequence-based comparisons may be 
overlooked in classical functional annotation protocols still widely used today. 
Increasing cases of proteins with similar structure and functions, but undetectable 
sequence similarity have driven development of more sensitive methods for structure-
function prediction (Brenner et al. 1998;Martin et al. 1998). 
3.3.2 From sequence to structure to function 
The fold recognition concept, initially implemented to identify analogous proteins 
with undetectable sequence homologies, has gained popularity in the 1990s. Fold 
detection appeared as a necessary tool due to the observation of structurally related 
proteins with dissimilar primary sequences. This may have arisen from convergent 
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evolution oftwo initially unrelated genes due to pressure exercised by external factors 
from habitats of two different species, or from rising demand of a cell to perform a 
given task. Fold detection in cases of low sequence homology thus opened new 
avenues for function inferences, however with the caveat that similarly folded protein 
structures with completely different biochemical functions do exist. 
The traditional approach to fold prediction is based on sequence-sequence or 
sequence-profile comparisons. Homology modeling for example utilizes the 
evolutionary information obtained from sequence alignments and an associated 
scoring matrix to predict the spatial arrangement of each residue. An immediate 
extension to the sequence-sequence comparison approach has emerged with the 
implementation of threading methods. This technique utilizes a template structure to 
compute position-specific alignment scores based on iterative calculation of 
substitution scores by replacing the side-chain of a residue with all other 19 naturally 
occUITing side-chains. Another approach to fold prediction is based solely on a first-
principle physical, but time-consuming, treatment. These ab initia methods take 
advantage of physical properties of atoms in order to calculate the free energy over an 
ensemble of prote in conformations and to simulate prote in folding. CUITent 
limitations in computation power, however, do not allow sufficient sampling 
flexibility to effectively predict protein folds via ab initia methods. A final dass of 
prote in structure prediction methods, termed meta-predictors, applies statistical 
methods to improve the accuracy of a collection of prote in structure predictions over 
that of individual methods. 
Meta-prediction is a simple yet powerful approach (Ginai ski et al. 2005) that 
utilizes a diverse collection of prediction algorithms as the basis for arriving at a 
consensus 3D-structural prediction for a query prote in sequence. Meta Servers belong 
to an online framework of meta-predictors that gather or implement, and then analyze 
models predicted by individual servers or methods. The principle behind meta-
predictors relies on observations that the most abundant low-energy conformation 
(from simulated structures generated by ab initia prediction protocols) is doser to the 
native structure than the conformation with the lowest energy (Ginai ski et al. 2003). 
This statement translates into the philosophy behind meta-predictors by inferring that 
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most abundant high-scoring models are closer to the native structure than the model 
with highest score (GinaI ski . et al. 2003). The consensus approach has experienced 
great success in this domain and is included in a series of biennial benchmark studies, 
CASP, a large-scale experiment launched in 1994 to assess protein structure 
prediction methods and presently at version 7. AlI results obtained by the published 
) 
CASP6 (version 6 of CASP) experiment, which was completed for the period ending 
in December 2004, indicate that meta-predictors are more accurate than any 
independent fold recognition methods (Wang et al. 2005). 
There exists several fully automated Meta Servers for consensus prediction. 
HistoricaIly, the first server, Pcons, implemented a neural network to uniformly scale 
the confidence score of models from various methods based on the expected accuracy 
of individual models (GinaI ski et al. 2005;Lundstrom et al. 2001). This approach 
outperformed any individual method included by Pcons by generating ~8-1 0% more 
correct predictions and with a significantly higher specificity. A second consensus 
prediction is 3D-Jury which, unlike Pcons, solely relies on the statistical significance 
of predicted models (GinaI ski et al. 2003). 
3.4 3D-Jury - a consensus fold recognition server 
3D-Jury (GinaI ski et al. 2003) is a simple yet powerful meta-predictor and is 
currently part of continuously-run structure prediction benchmark LiveBench and in 
CAF ASP evaluation of fully-automated fold prediction servers (Boume 
2003;Rychlewski, Fischer 2005). By including results from other meta-predictors in 
its consensus calculations, 3D-Jury has also eamed the name "meta-meta-predictor". 
During the course of this project, the 3D-Jury server included the Pcons meta-server 
for fold prediction (Wallner et al. 2003). In a similar fashion as in clustering of 
similar structures from ab initia simulations, 3D-Jury identifies, through a simple 
normalized summation over similarity scores between each model and aIl other input 
models, the best structure at the center of aIl predicted models. It thus can be 
considered as a non-energetic prediction method, since model ranking relies on the 
repeated occurrence of low-energy models rather than on the scores of the se models 
from independent prediction methods. A similarity score between a pair of 3D-
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models is defined as the number of corresponding Co.-atom pairs within 3.5 A of each 
other after optimum 3D-superimposition of the model. A similarity score of 40 
represents a threshold for reliable structural predictions, based on the observation that 
it corresponds to a -90% confidence that the underlying 3D-structures belong to the 
same class of protein fold (Ginalski et al. 2003). Two modes are implemented in 3D-
Jury: 1) The all-mode1 mode considers ail predicted models, white 2) the best-model 
mode discards aIl but the model from each server with the best similarity score with 
aIl other models. The set of models generated from the selected mode are then used 
for calculating the 3D-Jury score. At the time of this study, results from 15 servers 
from sequence-based comparisons to threading methods to meta-servers were 
gathered in the 3D-Jury system (http://bioinfo.pl/meta/). Data collected from servers 
harboring threading algorithms (mGenThreader, INUB, Sam-T02, FUGUEv2, and 
3D-PSSM), highly accurate sequence-only analyses (FF AS(03), Meta-BASIC(3), 
BasicDist, ORFeus2, Psi-BLAST, and Superfamily), and secondary structure 
predictors (PROFsec, PSI-PRED) were used as jury. 
In LiveBench6 experiments, 3D-Jury demonstrated high sensitivity on difficult 
targets, which are outliers from structural alignment of PDB entries within the same 
fold class (Rychlewski et al. 2003). In the same study, 3D-Jury was shown to produce 
the highest number of correct predictions in both difficult and easy targets using 
variations in the subset of model predictions. 
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ABSTRACT 
Ulriqllitin-sp«ific prat_ (USPr) emerge lU 
Irq reguImors of numerous uIhJar ,,--
and accmmt for tW buDc of Iamum üubiquiti-
fUlting enzymG (DUlb). TIoeir modullrr _ 
l>Irc, moltly __ al br Mtf'"'JU homo~ 
is believed tu deknrrine ~ reugraitiDn 
and subulluIar loadimtion. Currmtly, /1 1arge 
proportion of known launan USE' ~
~ not llruwflltal ei/her stnIctIlrIIlly or ~ 
tionally, induding ~gions bo/h witlrin and 
flanking Iheirclllll1yt1c cores. To extend the cvr-
~t Ilndemanding of 1aunan USPs, we applied 
œnsemw fold ~œpitiOll tu tW ~
œntmt of /he human USP firmlly. The moIt 
intemting discovery _ the marlced p-" 
of rdiably prftlicted ubiquili"..1ike (UBL) 
domairu in tlris family of enzymes. The UBL 
domain thus apf1e1ll'S tu be tW moIt frequatly 
occurring domain in the 1umum USP flltflilJl 
afier /he chllrllcteristic C'IItalylic dornain. The 
p-" of multiple UBL domabu per USP 
protein, lU weil lU of UBL domairu embeddaI 
in /he USP cIIIII1yt1c œ~, a.dd tu tW stnlctllrlll 
œmplaity cunmtIy rtIC08"= for ma"" 
DUBs. Pouib1e frmaional roIa of the lIeW/y 
lI1ICOVeml UBL domains of Iamum usp" 
including pro_ binding, and sulntrtm 
and protein target specificilies, lin discwsed. 
Proteiru 2007; 69;1-7. 
ID 2007 Wil~-Li5s. Ine 
Key words: consensus fold reœpitimr; tÜu-
b/quitl .... tionj proùwome; ubilfllltln; UBlo 
USP. 
INTRODUCTION 
Post-translational ubiquitination of proteins in eukaryotes govems cellular 
activities ranging from selective protein degradation by proteasomes to 
membrane protein trafficking. signal transduction. transcription. nuclear 
transpon. autophagy. and immune responses,l-4 Protein ubiquitination is 
catalyzed by the sequential action of El. E2. and E3 enzymes that activate 
and transfer ubiquitin or ubiquitin-like moditiers to the ~-amino group of 
an internallysine residue of target proteins.5•6 Ubiquitination is a reversible 
process. The isopeptide bond between ubiquitin and a substrate protein, or 
between ubiquitin molecules in a polyubiquitin chain, can be deaved by 
deubiquitinating enzymes (DUBs). which are also responsible for the activa-
tion of ubiquitin and ubiquitin-like modifiers by C-terminal processing of 
their precursors.7 A large number of DUEs have been disrovered and repre-
sent an emerging dass of ubiquitin pathway regulators. predominantly from 
eukaryotes.8 but also of bacterial and viral origins.9- 11 
New insights into molecular structures. biochemical activities. substrate 
speciticities and functions have been gained for the current inventory of 
DUBs over the past decade.7.8 Most known cellular DUEs are cysteine pro-
teases. induding those rrom the ubiquitin-specitic proteao;e (USP) structural 
class. which represents the bulk (over 50) of DUBs enroded in the human 
genome.8•12 Linle is known about the physiological function of most 
human USPs. and specitic substrates remain dusive. The current view is 
that the modular. multidomain architecture of USPs contributes to their 
speciticity with respect to the type of ubiquitin polymer and moditier. but 
perhaps more imponantly. to the targe! protein pan of the substrate.8 
Human USPs have highly variable amino acid sequences upstream and! 
or downstream of the catalytic core. A number of domains have been 
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annotated in these regions based on sequence homolob'Y,8,12 
. some alrt'ady' confinnl'Cl experilIIentaJly, for cxample, the 
ll{AF-like do main of human USP7, the DUSP domain 
of human USP1S, and the CS dnmain of human USPI9. 
However, a large proportion of the N- and C-terminal 
extensions of human USPs relllain structurally ,1I1d func-
tionally unannotated. Also, the size of their catalytic core 
domains varies from '"'-'300 to 1100 residues due to large 
sequences llncharacterized structurally, which may play 
fllnctional roles. 
Given the currently known and expected important 
(Cliniar l'oies of USPs, a detailed structural annotation of 
indiyidual family members of this dass of DUBs is an 
important step toward e1ucidating their molecular func-
tions in human health and disease. On this account, we 
have subjeeted the currently unannotated content of 
human us]> f.1fnily to advanccd structural bioinfonnatics 
techniques. The most impressive tinding of this predic-
tion exercise is the abund anee of ubiquitin-like (U 13l.) 
domains in this family of enzymes, both within and out-
side USP catalytic core domains. The newly uncovered 
UBL domains arc likdy to play important functional 
roles toward the substrate and target protein specifieities 
of human USPs. 
MATERIALS AND METHDDS 
Sequences of the currentJy known human USPs corre-
sponding to the C19 f.unily of the MEROPS peptidasc 
database (http://merops.sanger.ac.ukJ) were collected 
from the Genl3ank (http://www.ncbi.nlm.nih.gov/Gen-
bankl) and SwissProt (http://www.cxpasy.org/sprotll 
data bases. Only one sequence was sdected from those of 
multiple. isoforms reported for some USPs (gene.rally 
nearly identical mutation isoforms, othenvise the longest 
sequence was selected), thus leading 10 a nonredundant 
set of S4 distinct human USP sequences (see Supplemen-
tary Materia!). The boundaries of their catalytie core, as 
weil as ail their currently annotated domain.~ outside this 
core domain were obtained from the pfam (http:// 
www.sanger.ac.uklSoftware/Pfam/) and InterPrn (http:// 
www.ebi.ac.uklinterproJ) dat,lbascs and confirmed, when-
eyer ayailable, with actual structures retrie\'ed from the 
l'mtein Data Bank (PDB, http://www.rcsb.org/). The 
remaining unannotated sequence content was therefore 
defined by the sequences flanki ng or between the cur-
rently annlltated domains, as weil as inscI1ed in the cata-
Iytic core. ln the latter case, locating such insertions 
required (i) a multiple sequence alignment of ail S4 cata-
Iytic core sequences, which was perfor1l1ed with the 
MAFIT5 algorithl11,13 and (ii) comparisons with the 
minimal catal}"tic core domain dclineated by its available 
crystal structures from several human USPs (with l'DB 
IDs): 2 (2HDS), 7 (INBS, lNBF, 2F1Z), 8 (2GFO). and 
14 (2AYN, 2AYO). 
2 PROTEINS 
Structural domain detection of the currently unanno-
tated content of the human USP family was carried out 
at the Structure Prediction Meta Server (http://meta. 
bioinfo.pll), which assembles state-of-the-art fold recog-
nition methods, and provides a consensus scoring of the 
three-dimensional structure predictions generated for a 
given query sequence hy independent algorithms, using 
the 3D- Jury meta-predictor. 14 Short sequence stretches 
«40 residues) were not considered. Overly long contih'1l-
ous sequences (>800 residues) were split into shortcr 
fragments prior to fold recognition calculations. l1lis 
splitting was donc in two W,lyS: (i) generating thrce 
equal-length sequences corresponding to tJle N- and C-
termin;!l hah'es plus the central region of the same 
length, and (ii) following the consensus predictions of 
domain boundaries generated by the Meta-DP meta-
server (http://meta-dp.cse.buff.llo.eduJ).15 Considering 
the possibility of e1l1bedded domain folds, newly identi-
lied domains were excised out of the original query 
sequence (typically longer), and the resulting flanking 
regions were 1l1erged and subjected to a new round of 
fold detection. Finally, the excised sequences of ail newly 
mapped domains were resubmitted to the. Structure Pre-
diction Meta Sen'er to obtain the final template ranking, 
rc1iability indicators, query-to-te1l1plate sequence align-
ments and secondary structure predictions. 
The reliability of fold assignment was based primarily 
on the 3D-Jury confidence score, which was calculated 
using the standard settings under which the score was 
found to correlatc to the number of correctly predicted 
residues. 16 Accordingly, a confidence threshold of 50 for 
the 3D-jury score translates into a prediction reliability 
of over 90%. Fur shorter sequences « 100 residues), the 
3D-jury contidence cut-off was lowered to 40. A qualita-
tive evaluatÎon of the qucry-to-tcmplate sequence and 
secondary structure alignments was also carrÎed out to 
support the assessment uf each top-ranked structural 
assignment. 
Secondary structure predictions were based on four 
methods: PROFsec,17 PSI-PRED.18 and SAM-TOZ with 
DSSP and STRIDE alphabets. l9 A consensus was th en 
derived for each sequence by (i) majority voting over ail 
four methods for a-helices and J3-strands, and (ii) SAM-
T02 predictions of G-helices, a secondary structure not 
available from the other prediciion methods. The multi-
ple sequence alignment of the identitied UBL domains 
was assembled starting from individual query-to-telllpJate 
sequencc alignlllents top-r,1I1ked by 3D-jury consensus 
fold recognition. This preliminary alignment was furtller 
refincd by: (i) considering the structure-based sequence 
alignment between tbe top-ranked UBL templates, which 
was gencrated with the Expresso (3D-Coffee) program,20 
and (ii) minor local improvcments in the sequence und 
secondary structure alignments among predicted UBL 
dOlllains. Sequence homology-based dustering of prc-
dicted UBL domains of USPs was derived with the Clustal 
DOl IO.100.!fprol 
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Deteot:ion of UBL Domaine ln Human USPe 
W program21 uSÎng the PAM350 scoring matrix, given the 
seqllence divergence of thi.' UBL fi)ld. 
RESULTS 
One approach loward extending the Cl1rrent sequence-
homology-based dc)main ,lI1notation of human USPs is 
to detect structural relationships that have only remote 
or no underlying sequence horn<llogy. 'fhis is the objec-
tive of fnld recognition ll1ethods, Thus, wc suiJjeeted thc 
unannotated sequence content of the human USP family 
to the consensus protein structure prediction method 
3D- lury.l4, 16 This widdy lIsed melil-prcdktor performs 
consensus scoring over the 3D model, generated hy 
state-of-the-art fold recognition algorithms, <lnd ranked 
as a top-pcrformer at the lMest CAS!', CAFASP, and Live-
Bench prediction contests.22,23 We also have reecntly 
employed 3D-Jllry to predict the USP-like structure and 
infer the deubiquîtinating activily for the SARS coronavi-
rus papain-like protease,24,25 predictions whkh wert: 
experilllentally confirmed bu th functiol1ally and ,tmctur· 
<lUy.26-28 
One of the most interesting result, ,lemming oui of 
Ihi, analysis was the prediction of llhiquitin-like (UBL) 
dornains in an unexpectcdly high Ilumber of hum,ll1 
USP, (Fig, 1 Al, These UBL Jorn,lins were predkted with 
high reliability as judged by the statistically significant 
3D- fury scores obtained for the correspollding USP 
sequences af,rainst nUrllcrolls UBL templates (see Slip ple-
mentaiT Materia\). Consistent with the fold recognition 
data, the newly identilÎed UBL dOllwins fo!low the con-
sensus sccondary structllre and the common lÎngerprint 
sequence characteristic to the ubiqllitin sllperfold (Fig. 
1 B).29 
As shown schematically in Figure 1 A, the prevÎollsly 
Ilnannotated UBL domains detected for various human 
USPs by our structural bioinforl1latics analysi, are pres-
ent both imide and outside their catlllyrk core domains. 
Ubiquitin-like domains nested imide catalytic core 
dom.lins are found in the human USPs 4, 6, Il, 15, 19, 
31, 32, and 43, ln ail these enzyme" the UBL domain 
insertion occurs at highly homologous positions, spedfi-
cully, in the middle of the cin:ularly pl'rmutcd Zn-tlnger-
like dOl1ll1in, itself nested within the catalytic core 
between the IWo sub-domains of the papain-like fold.30 
The nested UBL dumain would !Je inscrted in thes.; USPs 
between the f3-strancl and the u -hdix that arc graftcd 
onto the four-stranded f3-ribbon of the drcularly per-
l1luted Zn-finger and are lltilized for its attachment to 
the C-terminal sub-dOllli\Ïn of the papain-like fold (Fig. 
1 Cl, as obscrvcd in the crysml structures of several 
USp,) [-33 ln ('ach case, the inserted UBL domain is 
clin:,tly fullowed bya region of about lïO·240 residut'l:l 
(depending on the enzyme) beforc the remaincler of the 
circularly pcrmuted Zn·finger-like f(Jld (Fig, tA). No fold 
DOl lO, 1()()2/l'ro! 
similarity l'ouM !Je detected for any of these regions, 
which, for most parts, lack prcdicted secondary structure 
clements. An interesting "\Illriation is observed for USP19, 
where an annotated MYND Zn-linger domain of about 
45 residues i5 intercalatccl immediately after the nested 
UBL domain and before the large, mostly llilstructured, 
region. 
The remuinder of the newly identified UBL domains 
are located outside the boundarics of the catalytic core 
dOl11uin (Fig. lA), Ubiquitin-Iike donmins N-terminal to 
the catalytic core are detected in human US!'s 4, 9X, 9Y, 
11, 15, 24, 32, 34, and 47. Thus, USPs 4, Il, 15, and 32 
teature two UBL domains, one inside and the other one 
immediately upstream to the catalytk çore domain. 
Interestingly, the predicted N-temlinal URL domain in 
ail these four USP, is preceded by a DUSP domain.34 
'Ille single N-terminal UBL domains of US!>, 9X, 9Y, 24, 
and 34 are predicted to be l1anked on both sides by ,111-
œ·helical domains (not shown), Multiple UBL domains 
were detected in the C-tcrminal extensions relative to the 
cataly1ic core of human USPs 7 (four domains), 40 (two 
domains), and 47 (three domains; a fOllrth UBL domain 
is prcdicted upstre,lm to the catalytic core). 
DISCUSSIDN 
Based 011 primary sequence homo)ogy, UBL domains 
have been previously detected on'Iy in the N-termimll 
part nf human USP14,35 and in the C-terminal end of 
human USP4S. 12 ln the former case, the solution NMR 
structure of the UBL do main of 11l0use USPI4 (l'DB ID: 
lWGG; 97°/t. sequence identity to the human domain) 
c(mfirms this structural assignment. The exquisite prom· 
i,cu ity of the ubiquitin superfold to variations in primary 
sequence,29 may have preduded the detection of most 
UBL domains b}' simple applications ~1f standard homot-
ogy tooL~ sucll as PSI-BLAST,36 possib)y leading to their 
llnder-representation in the currently <lV'dilablc public 
annotations of USPs. Supporting thi, idea, the only other 
previously reported UBL domain of il lm man USP, that 
nI' USP9Y, resultcd from a fold recognition-based annota-
tion study targeted to the male·spedfic- region of the 
human y chromosome.37 
The present structural bioinformatics i.lnalysis of the 
(urrentl)' unannotated content of the endre h\umm USP 
f<lmily significantly augments tlle existing annotation 
with the addition of 26 UBL domains From 15 distinct 
human USPs. Thus, the UBL domain ean be regarded as 
the most frequentl)' occurring domain in the hllman USP 
famil)', atter the characteristic pl:ote\lse core domain.S,12 
We "mnot exclude the possibility that a few other UBL 
domains, perhaps more remotely related to the currently 
known mcmbers of the ubiquÎtin superfold,29 l1<1ve 
escaped our fold detection employing the existing bcst-
performing algorithms and the currcnt PDB content. For 
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examplc, sevcral other putative UBL domains from USPs 
7,40, and 47 were detected with scores below the signifi-
canee threshold and therefore not reported hcn'. The 
occurrence of multiple UBL domains pel' USP protein, as 
weil as of UBL dOll1ains embeddcd in the USP catalytic 
core (hence coll1prising three distinct talds in a nested 
rather than successive type of assembly) add to the struc-
turai cOll1plexity that is currently being recognized for 
many DUBs. 
The marked presence of UBL domains in human USPs 
is likcly to have profound functional consequences in this 
dass of enzymes, primarily via (i) modulation of enzy-
matie .activity and specificity, and (ii) rccruitmcnt of 
nonsubstrate partners. In principle, due to structural 
similaritics to ubiquitin, modulation of USP enzymatic 
activity by Uill. domains could arise from the trivial 
action of competing directly with uhiquitinated sub-
strates for the ubiquitin binding site on the Zn-finger-
like domain, thlls acting as auto-inhibitory domains. The 
newly identitied UilL dOll1ains may also affect the enzy-
matie specitlcities of their USl's tmvard the substrate pro-
tein part or toward the ubiquitin part of the substrate 
conjugate. Owing to their proximity to the Zn-finger-like 
domain implicated directly in ubiquitin docking,31,33 
the UilL domains nested within the catalytic core (Fig. 
1 A and 1 C) may affect the specificities of these USPs 
\Vith respect to the degree (mono/di/tetra/poly) and type 
(e.g., K48/K63, branchedJlinear) of polyubiquitination, 
or to the type of modifier (e.g., ubiqllitin, ISGI5, 
NE008). For instance, an intact metal-chelating Zn-fin-
ger-like domain of human USPI5, which features a 
nested UIlI. domain, is essential for degradation of K48-
bnlllched polyubiquitin ch.lins but not for hydrolysis of 
the ubiquitin-GFP fusion.38 This, in light of the fact that 
USP7 can degrade polyubiquitin substrates,39 in the ab-
sence of the metal-chelating ability of its Zn-finger-like 
domain alld of a nested UIlI. domain, suggests that the 
metal center might stabilize or position the nested UBL 
dOlllain in order to allow polyubiquitin recognition by 
some USPs. 
More broadly, UBI. domains can engage in specifie 
interactions with domains of both substrate and nonsub-
strate protein targets. In the latter case, su ch specific 
interactions will determine noncatalytic properties of 
USPs such as localization, trafficking, and participation 
in intraccllubr and signaling pathways, althol1gh they can 
also affect the USP enzymatic activity and specificity. For 
example, human USP 14 and its yeast hOllllllog Ubp6 
bind through their N-terminal UilL do main to the 26S 
proteasome, which also results in a dramatic increase of 
their catalytic activity.32,40-42 Proteasome-associated 
DUBs can act catalytically to rernove (poly)ubiquitin 
before proteasomal degradation, thus serving in the edit-
ing of poorly targeted substrates and llbiquitin recycling, 
~r noncatalytic~lIy to delay proteasornal degradation and 
regulate both the nature and magnitude of proteasornal 
DOl 10.1ex)lIprol 
activity.43 lt is tempting to speculate that other human 
USPs would also have the ability to bind directly to pro-
teasome slIbunits via some of thcir UBI. dornains identi-
fied here. The Uill. domain of Illouse USPI4, as weil as 
other UBI. domains known to associate. with proteasome, 
for example, from hl1man ubiquilins 2 and 3, or ONA 
d'lInage repair protein Rad23A,44-46 were retrieved 
among the high scoring structural templates for newly 
mappcd U131. domains of several USPs (Sl'e Supplcmen-
tary Material). In this context, it is also worth to note 
the association of human USP 15 with the eOP9-signalo-
sorne (CSN), which has subllnits similar to campements 
of the 26S proteasome lid comple.".38 Dctection of the 
URL fold in USP 15 snggests that the rnechanisrn of CSN-
association of US!' 15 might resemble proteasol11e-associa-
tion of USPI4, that is, direct interactions via UBL 
domains. 
Functions other than proteasome and CSN binding 
.:an also be anticipatcd, at least in sorne cases, givcn the 
notorious functional variability within the ubiquitin do-
main sl1perfold, comprising ubiquitin, ubiquitin-likc 
modifiers and internai UBI. structures. 29 Generally, the 
interaction surface seems not to be conserved within the 
ubiquitin superfold and almost every clement of the fold 
is llsed in protein recognition, although interactions with 
one protein family tend to use the same surface.29,47-49 
A vast repertoire of ubiquitin-binding do mains (UilDs) 
is known to interact with members of the llbiqllitin 
superfold. Ubiquitin-dependent signaling pathways 
include UlM, UBA, UilL, eUE, GAT, GLUE, and various 
types of Zn-fingers such as ZnF-A20, NZF, and ZnF-
UIlP, among other UilDs.48 Outside the ubiquitin path-
ways, small GTPases represent the prevalent fold interact-
ing \Vith UBI. domains. The presence of UIlOs can be 
diagnostic of putative substrate or nonsubstrate protein 
targets, largely unknown for llloSt Uill. dOlllain-contain-
ing human USPs. 
While the ubiql1itin-like tald was abllndantly detected 
in the relatively large family (54 members) of human 
USPs, its presence in USPs from older ellkaryotes may 
indicate that UllL domains represent important func-
tional features that Wère conserved during evolution in 
this c1ass of enzymes. Indeed, a fold recognition analysis 
of the unannotated sequence content of the USP family 
from the Saccharomyces œreFis;'l" yeast (16 enzymes, 
Ubpl to UbpI6), detects UBL domains in Ubp12 and 
Ubpl5, the yeast homologs of human USPl5 and USP7, 
respectively, in addit.ion to the known UBL domain in 
Ubp6 (see Supplementary Material). Another compelling 
example suggesting the importance of the Uill. domain 
as a key structural and putatively regulatory module in 
the USP class of OUBs is provided by the SARS corona-
virus p<lpain-like protease. This viral enzyme, whose pri-
mary function is in viral replication via polyprotein proc-
essing, not only acquired the USP molecular architecture 
,md deubiquitinating activity common to the COITe-
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sponding host œil enzymes, 11,26,27 but it also ieatures n 
UBL do main (;llbeit about 20 residues smaller than llbiq-
uitin).28 
The UBL domains detccted in human USPs do not 
show, in the sequence following their C-terminal 13-
strand, similarity to the ubiquitin precursor proœssing 
site, which OCClUS aiter the llbiquitin C-terminal 
sequcncc 7:1LRGG7fi' Wc the.rel()re conclude that the y arc 
internai noncleavable UBL domains. However, a struc-
turai relationship to ubiquitin has been recently proposed 
lllf human USP l, which is inactivated hy auto-cleavage 
after an internai uhiquitin-like di-glycine motif.50 The 
cleavage occurs in the middle of a 140-rcsidue insertion 
in the minimal USP catalytic core domain, based on the 
available crystal structures of USPs 2, 7, Il, and 14. How-
ever, we eould not deteet the UBL fold in the 70-residue 
inserted sequence preccding the processing site. It is 
possible that in the case of USPI, key sllbstrate inter<1e-
tions between its eatalytic groove 56-S I subsites and its 
residucs 6661GLLGG671 preceding the cleavage site, which 
are homnlngolls to the ubiquitin C-terminal sequence 
71 LRLRGG 76, are sufficient for cleavage without the need 
of additillnal interactions from the rest oi the ubiquitin 
fnld. l.ike the acquisition of noncleavable UBL domains, 
the utilization of a deavable internai ubiquitin-like C-ter-
minai motif in USPI provides another filscinating e.xam-
pIe for the rcuse of structural clements spccific to the 
lIbiquitin signaling pathways towards increasing their 
own reguhltory capabilities and functional diversity. The 
structural hioinformatics an:llysis reported hcrc providcs 
valuable information that can spur further strllcture-
flll1ction characterization studies in this class of dcubiqll-
tinatiilg enzymes. 
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Figure SI. Curated complete query-to-target assignment obtained by 3D-Jury consensus 
structure prediction for all newly identified UBL domains of human USPs (i.e., excluding those 
from USPI4 and USP48). See the Materials and Methods section of the main text for details on 
3D-Jury and its present application to human USPs. 
3D-Jury scores are coded using four shades of gray (see legend). For ail newly predicted 
UBL domains, there is at least one UBL structural template with 3D-Jury higher than 40. Only 
the highest of the scores corresponding to different fold recognition methods for the same 
structural template (i.e., the same PDB entry) is plotted. The same applies for independent 
structures of the same template (e.g., PDB entries 1 UBI and 1 UBQ of ubiquitin). 
The structural templates are described at the top of the figure by their PDB codes, protein 
name and species. Ali but three of these templates belong structurally to the ubiquitin 
superfamily, classified in the SCOP data base (http://scop.berkeley.edu/) under code d.15.1 or 
54236. The only exceptions are: (i) for the USP7 sequence 792-883, where two PB 1 domains 
were retrieved Wilh 3D-Jury score ~ 40 (PDB codes IIPG and lVD2), and (ii) for the USP47 
sequence 1221-132 l, where a 2Fe-2S ferrodoxin-like domain was retrieved with 3D-J ury score> 
30 (PDB code 1 E7P). Both the PB 1 domain (SCOP code d. 15.2 or 54277) and the ferrodoxin-
like domain (SCOP code d.15.4 or 54292) belong to the p-grasp ubiquitin-like fold (SCOP code 
d.15 or 54235) and are closely related to the archetypal ubiquitin superfamily. No other folds 
were detected with a score higher than 30 for any of these UBL domains of human USPs. Note 
that some of the template protein structures identified in Figure S J contain multiple domains; in 
these cases it is only their UBL domains that were identified as structural templates. 
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lM94 Hubl(5.cerevisioe) 
1WGG USP14 (mouse) 
1WH3 2'-S'-oIigoadenyl.te ,ynthetaselike (pS9 DASU protein (human) 
1] BC Proteasome ligase interaction component (PUC) 2, Ubiquilln 2 (human) 
1EUV Smt3 (5_wevislae) 
1BTO RUB 1 lA thallana) 
1WGD Homocysteine~responsive endoplasmÎc reticulum~resident protein (HERP) 1 (human) 
1WXV BC12-binding ath.oogene (BAG) 1 (human) 
1WZO SUM0-2Ihum.n) 
1WX9 HlA~B associated transcript (BAn 3b (human) 
1WE7 Splicing factor 3 ,ubunlt 1 (SF3, t20) (hum.n) 
1 TTN Dendritic ceU--derived ubiquTtÎn-like protein (OC-UbP) (human) 
lASR SUMO-l (human) 
1NI2 Erzin (human) 
1ESW Moesin (human) 
1319 Radixin (mou,.) 
1IPG Bud emergence protein (BEM) 1 - PBl domain (5. œrevlsÎae) 
lUH6 Ubiquitin-like IUBL) proteln 5 (mouse) 
1VD2 Protein kinase C iota type (PKCI) - PBl domain (human) 
1V2Y Hypothetical protein 3300001 G02Rik (mou,e) 
10QY UV-radiation damage repair protein (RAO) HR23a (human) 
1WE6 Probable splicing factor 3 subunit 1 (A. rhafiana) 
1WF9 Hypothetical protein NPl4 family (A thaliana) 
lMG8 Paron (mouse) 
2 BWF Dsk2(5_ cer.v~ia.1 
1VCB 80ngin B (humanl 
1L7Y Hypothetical prote in ZK6S2.3-NESG (Celegan,) 
1E7P Fumarate reductase iron-sulfur protein (W.sucônogenes) 
2CR5 Hypothetlcal protein DOHBS229BE (mou,.) 
N 
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Figure S2. Novel UBL domains reliably detected by consensus fold recognition in the 
USP family from Saccharomyces cerevisiae yeast. Ubiquitin-like domains were recognized in 
yeast Ubpl2 and Ubpl5 between indicated boundaries, with JO-Jury scores above the 
significance cutoff of 40. Yeast Ubp6, the only yeast USP (out of 16 family members) previously 
annotaled to contain a UBL domain, is also shown. 
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Table SI. Database accession numbers for the 54 human USP sequences used in this work. 
Name 
USP1 
USP2 
USP3 
USP4 
USP5 
USP6 
USP7 
USP8 
USP9X 
USP9Y 
USP10 
USP11 
USP12 
USP13 
USP14 
USP15 
USP16 
USP17 
USP18 
USP19 
USP20 
USP21 
USP22 
USP24 
USP25 
USP26 
USP27 
USP28 
USP29 
USP30 
USP31 
USP32 
USP33 
USP34 
USP35 
USP36 
USP37 
USP38 
USP39 
USP40 
USP41 
USP42 
USP43 
USP44 
USP45 
USP46 
USP47 
USP48 
USP49 
USP50 
USP51 
USP52 
USP53 
USP54 
GenBank 
29791616 
12804195 
55770886 
40795665 
4758564 
4507857 
41281376 
11641425 
4759296 
24307889 
24234683 
4827050 
14149627 
5454156 
551291 
15928868 
57529246 
49899220 
57284140 
113429832 
16507200 
10190742 
14249222 
42415503 
22550104 
42516567 
41056187 
35250686 
32698744 
27545313 
56550051 
51094456 
40788175 
14149817 
56204652 
31377709 
71774197 
52630449 
55959716 
45267835 
41152235 
41281527 
56912182 
40255121 
SwissProt 
P45974 
075317 
092995 
09Y2K6 
09UK80 
09UPT9 
09UPU5 
09P2H5 
09NVE5 
Q70BM7 
28 
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Table S2. Database accession numbers for the 16 USP sequences from budding yeast. 
Name SwissProt 
Ubp1 P25037 
Ubp2 001476 
Ubp3 001477 
Ubp4 P32571 
Ubp5 P39944 
Ubp6 P43593 
Ubp7 P40453 
Ubp8 P50102 
Ubp9 P39967 
Ubp10 P53874 
Ubp11 P36026 
Ubp12 P39538 
Ubp13 P38187 
Ubp14 P38237 
Ubp15 P50101 
Ubp16 002863 
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4.1 Personal contributions 
Beginning from an idea initiated by Dr. Sulea that long sequences from 
unstructured regions in human USPs may contain important information about the 
function of each USP, 1 have carried out the primary work of this research project and 
produced results as presented in the article. Under the guidance of Dr. Sulea and Dr. 
Ménard, 1 have generated and refined multiple sequence alignments, elaborated the 
procedure for sequence selection and analysis, and analyzed final results. 1 have also 
worked closely with Dr. Sulea, who contributed most to the production of the text, for 
the elaboration of the paper. 
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Chapter 5 Conclusion 
In this research project we applied multiple' sequence alignment and 3D-fold 
recognition to address the current limitations of identifying structural and functional 
features of 54 human USPs. We have identified a multitude of previously unknown 
domains inc1uding Zn-fingers and EF-hands. The most important discovery is the 
remarkably high occurrence of ubiquitin-like (UBL) domains integrated, not only at 
both termini of USPs but also within previously un-annotated segments embedded 
within the catalytic core. These key observations increase our understanding of the 
structural organization of USPs by presenting a new dimension in the structural and 
functional complexity ofthese enzymes. 
In addition to the presence of integral UBL domains in human USPs, we have 
uncovered many other structurally and functionally diverse regions with significant 
confidence level. For example, further analyses of the sequences in the upstream and 
downstream regions of newly identified UBL domains (in USP9X, USP9Y, USP24, 
and USP34) revealed long stretches of armadillo repeats, which may form an all-
alpha helix bundle much like nuc1ear transporters, and interact with nuc1ear receptors 
and transporters (Figure 3). We have also identified an additional CS domain 
immediately upstream of the known domain (PDB: 1 WHO). The occurrence of a-
helical structural arrangement similar to nuc1ear receptors and beta-catenin, and 
generally known as armadillo (ARM) repeats, was found in many USPs (Figure 3). 
Among them, USPs 9X, 9Y, 24, and 34 harbor an UBL domain at the heart of their 
long ARM stretches. We believe that these alI-alpha regions may interact with 
nuclear receptors and transporters and also modulate Wnt signaling and cell adhesion 
(Figure 3). Finally, a zinc-finger UBP domain was identified in USP39 where it may 
play a role in Ub binding and hydrolysis (Figure 3). 
Our findings present leverage for future investigations on the role of these newly 
discovered domains in substrate specificity and subcellular localization of USPs as 
weIl as their physiological functions in human diseases. While further biochemical or 
biophysical analyses will be required to validate the accuracy of our -predictions, our 
present results provide solid indication of the utility of structure-based functional 
32 
prediction by associating sequences lacking any detectable homologies. The 
consensus method for fold prediction and recognition is a relatively new concept 
which may require time to be fully acknowledged. We believe that this type of 
approach should be integrated routinely into first degree functional assignments 
where sequence-based comparisons would fail. 
-""" 
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Identification of 
additional folds 
___ Protease Domain ___ zf-UBP 
___ UBL 
WD-Repeat 
___ cs 
___ Neurocalcin EF-Hand 
___ Nue. trans. (ARM) Beta-eatenin (ARM) 
Figure 3: Identification of novel folds within the USP family with catalytic core 
represented as protease domain in gray. In addition to the frequent occurrence of UBL 
domains in the 54 USPs analyzed, nuclear transporter-like and be0074a-catenin-like 
armadillo repeats were identified at both N- and C-tenninal regions of USPs 9X, 9Y, 
24, 34, 35, and 38. Zinc-finger UBPs were found in USPs 39 and 51. A novel CS 
domain was identified in USP19. The all-beta sheet WD-repeat region was found in 
USP52. Two EF-hands with close resemblance to those in neurocalcin were identified 
in USP32. 
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